GlaxoSmithKline Pharmaceuticals Limited — Others, 16-05-2025: Spurt in Volume

GlaxoSmithKline Pharmaceuticals Limited has clarified that the recent surge in its trading volume is driven solely by market activity, with no undisclosed material information involved. The company confirms it has transparently shared all relevant operational and price-sensitive updates with stock exchanges. This assures shareholders that the trading spike does not reflect any hidden developments impacting the stock.